Evidence map›Paper›PMID 38448466›Full record

ReviewScientific reports2024

Emerging roles of SIRT1 activator, SRT2104, in disease treatment.

Ning Chang, Junyang Li, Sufen Lin, Jinfeng Zhang, Weiqiang Zeng, Guoda Ma, Yajun Wang

Open access · goldAbstract readReview
In one paragraph

Review in Scientific reports, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 58 papers.

0numbers the graph read from it
0cells of the map it votes in
58citing papers in PubMed
24.1field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

58 citing papers in PubMed, 70 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. SIRT1 in Neurodegenerative Diseases: Molecular Mechanisms, Disease Relevance, and Therapeutic Potential.FASEB journal : official publication of the Federation of American Societies for Experimental Biology · 2026
    Review
  5. Article
  6. Review
  7. Review
  8. Review
  9. Review
  10. Article
  11. Review
  12. Integrative Approaches to Treating Cellular Senescence in Kidney Disease.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2026
    Review
  13. Review
  14. Article
  15. Article
  16. Review
  17. Review
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Ning ChangShunde Women and Children's Hospital, Guangdong Medical University, Foshan, China.
Junyang LiShunde Women and Children's Hospital, Guangdong Medical University, Foshan, China.
Sufen LinShunde Women and Children's Hospital, Guangdong Medical University, Foshan, China.
Jinfeng ZhangShunde Women and Children's Hospital, Guangdong Medical University, Foshan, China.
Weiqiang ZengShunde Women and Children's Hospital, Guangdong Medical University, Foshan, China. 79776481@qq.com.
Guoda MaShunde Women and Children's Hospital, Guangdong Medical University, Foshan, China. sihan1107@126.com.
Yajun WangShunde Women and Children's Hospital, Guangdong Medical University, Foshan, China. wangyajuny1977@aliyun.com.
Guangdong Medical College · CN

Funding

GuangDong Basic and Applied Basic Research Foundation 2022A1515140167State Doctor Startup Fund of Shunde Women and Children's Hospital of Guangdong Medical University 2020BSQD002State Doctor Startup Fund of Shunde Women and Children's Hospital of Guangdong Medical University 2020BSQD003State Doctor Startup Fund of Shunde Women and Children's Hospital of Guangdong Medical University 2021BSQD001
6 · The paper itself

Abstract

Silent information regulator 1 (SIRT1) is a NAD

Indexed as

Heterocyclic Compounds, 2-RingSirtuin 1Databases, FactualPubMedHeterocyclic Compounds, 2-RingSirtuin 1SRT2104Clinical trialsDisease treatmentPreclinical researchSIRT1SRT2104

Identifiers

PMID38448466
PMCPMC10917792
OpenAlexW4392517696

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.